Literature DB >> 385772

Murine B cell leukemia (BCL1): organ distribution and kinetics of growth as determined by fluorescence analysis with an anti-idiotypic antibody.

K A Krolick, P C Isakson, J W Uhr, E S Vitetta.   

Abstract

The life history of a transplantable B cell leukemia (BCL1) that arose spontaneously in a BALB/c mouse is described. Animals bearing this tumor live from 2 to 4 months in apparently good health despite massive splenomegaly and leukemia. Antibody to the idiotype or gamma light chain of the tumor IgM was used in conjunction with the fluorescence-activated cell sorter to identify tumor cells in the BCL1-bearing mice. The results suggest that these cells multiply and differentiate in the spleen and subsequently emigrate to the blood. Tumor cells do not recirculate as evidenced by their failure to enter the thoracic duct or to infiltrate lymph nodes to a significant extent. During tumor growth, a population of T cell blasts appears that may be involved with an immune response against the tumor.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 385772

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Visualization of immune response kinetics in full allogeneic chimeras.

Authors:  Gregory Elkin; Tatyana B Prigozhina; Shimon Slavin; Olga Gurevitch; Sofia Khitrin; Igor B Resnick
Journal:  Am J Blood Res       Date:  2011-08-22

2.  Activation-specific interactions among B-lymphocyte plasma membrane proteins.

Authors:  M G Goodman; R L Wolfert
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

3.  CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD.

Authors:  Suparna Dutt; Jeanette Baker; Holbrook E Kohrt; Neeraja Kambham; Mrinmoy Sanyal; Robert S Negrin; Samuel Strober
Journal:  Blood       Date:  2011-01-14       Impact factor: 22.113

4.  BCL1, a murine model of prolymphocytic leukemia. II. Morphology and ultrastructure.

Authors:  M J Muirhead; J M Holbert; J W Uhr; E S Vitetta
Journal:  Am J Pathol       Date:  1981-12       Impact factor: 4.307

5.  Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.

Authors:  K A Krolick; C Villemez; P Isakson; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  BCL1, a murine model of prolymphocytic leukemia. I. Effect of splenectomy on growth kinetics and organ distribution.

Authors:  M J Muirhead; P C Isakson; K A Krolick; J W Uhr; E S Vitetta
Journal:  Am J Pathol       Date:  1981-12       Impact factor: 4.307

7.  T cell-derived B cell growth and differentiation factors. Dichotomy between the responsiveness of B cells from adult and neonatal mice.

Authors:  E Pure; P C Isakson; J W Kappler; P Marrack; P H Krammer; E S Vitetta
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

8.  In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.

Authors:  K A Krolick; J W Uhr; S Slavin; E S Vitetta
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

9.  Acquisition of cell surface IgD after in vitro culture of neoplastic B cells from the murine tumor BCL1.

Authors:  P C Isakson; J W Uhr; K A Krolick; F Finkelman; E S Vitetta
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

10.  T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells.

Authors:  P C Isakson; E Puré; E S Vitetta; P H Krammer
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.